Yunyi Wang

Yunyi Wang

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 March 2024 in Journal of Pathology and Translational Medicine
Verified
Journal Article
Open access
PDF file
YLYi Ariel Liu
Yi Ariel Liu
Phyu P AungPhyu P Aung
Phyu P Aung
YWYunyi Wang
Yunyi Wang
JNJing Ning
Jing Ning
PNPriyadharsini Nagarajan
Priyadharsini Nagarajan
Woo Cheal ChoWoo Cheal Cho
Woo Cheal Cho
Background: Although trichorhinophalangeal syndrome type 1 (TRPS1) was initially thought to be highly sensitive and specific for carcinomas and mesenchymal tumors of mammary origin, more recent data suggest its expression is not limited to breast neoplasms but also can be seen in other cutaneous neoplasms, such as extramammary Paget disease and squamous cell carcinoma (SCC) in situ.Methods: Two-hundred cases of non-melanocytic cutaneous neoplasm, including basal cell carcinomas (BCCs) (n = 41), SCCs (n = 35), Merkel cell carcinomas (MCCs) (n = 25), and adnexal neoplasms (n = 99), were tested for TRPS1 expression using a monoclonal anti- TRPS1 rabbit anti-human antibody.Results: TRPS1 expression was present in almost all cases of SCC (94%), with a median H-score of 200, while it was either absent or only focally present in most BCCs (90%), with a median H-score of 5. The difference between BCCs and SCCs in H-score was significant (p < .001). All MCCs (100%) lacked TRPS1 expression. TRPS1 expression was frequently seen in most adnexal neoplasms, benign and malignant, in variable intensity and proportion but was consistently absent in apocrine carcinomas. All endocrine mucin-producing sweat gland carcinomas (EMPSGCs) (100%, 6/6) showed diffuse and strong TRPS1 immunoreactivity, with a median H-score of 300, which was significantly different (p < .001) than that of BCCs.Conclusions: Our study shows that TRPS1 may be an effective discriminatory marker for BCCs and SCCs. It also has a role in distinguishing BCCs from EMPSGCs.

15 July 2024 in Dermatopathology
Verified
Journal Article
Open access
PDF file
MKMoon Joo Kim
Moon Joo Kim
YLYi Ariel Liu
Yi Ariel Liu
YWYunyi Wang
Yunyi Wang
JNJing Ning
Jing Ning
Woo Cheal ChoWoo Cheal Cho
Woo Cheal Cho
Although extensively studied in cutaneous epithelial neoplasms, the TRPS1 immunoreactivity in cutaneous mesenchymal neoplasms and tumors of uncertain differentiation (CMNTUDs), such as atypical fibroxanthoma (AFX), remains largely unexplored. We assessed TRPS1 immunoreactivity in 135 CMNTUDs, comprising 46 fibrohistiocytic/fibroblastic tumors, 28 vascular tumors, 24 peripheral nerve sheath tumors (PNSTs), 21 tumors of uncertain differentiation, and 16 smooth muscle tumors. Additionally, we included selected cases of melanoma with spindled cell morphology or desmoplastic features (n = 9) and sarcomatoid squamous cell carcinoma (SSCC) (n = 5) to compare TRPS1 expression patterns with those of AFX. TRPS1 expression was prevalent in dermatofibromas (24/24), leiomyomas (8/8), AFXs/pleomorphic dermal sarcoma (PDS) (20/21), dermatofibrosarcomas protuberans (14/22), and leiomyosarcomas (6/8). It was uncommon in angiosarcomas (3/20), Kaposi sarcomas (2/8), and neurofibromas (5/17) and absent in perineuriomas (0/2). AFXs/PDS exhibited the highest median H-score of 240, contrasting with minimal TRPS1 immunoreactivity in vascular neoplasms and PNSTs, with median H-scores consistently below 10. Significant differences in H-score were observed between AFXs/PDS and angiosarcomas (p < 0.001), melanomas (p < 0.001), and leiomyosarcomas (p = 0.029). However, no significant difference was found compared to SSCCs, suggesting limited discriminatory power of TRPS1 in this context. This study sheds light on TRPS1 expression patterns in a subset of CMNTUDs, extending beyond prior studies primarily focused on epithelial tumors, while underscoring potential pitfalls associated with TRPS1 immunohistochemistry.

9 September 2026 in Cancers
Verified
Journal Article
Open access
PDF file
BEBita Esmaeli
Bita Esmaeli
YWYunyi Wang
Yunyi Wang
TLTracy Lu
Tracy Lu
JNJing Ning
Jing Ning
AMAmy Moreno
Amy Moreno
JDJames Matthew Debnam
James Matthew Debnam
Background: To determine if certain clinical and radiologic features of lacrimal gland adenoid cystic carcinoma (LGACC) on pre-operative MRI were associated with the treatment decision to perform orbital exenteration versus eye-sparing surgery. Methods: All consecutive patients with LGACC treated by orbital exenteration (Group 1) versus eye-sparing surgery (Group 2) from June 2007 to March 2024 were identified through a search of the primary author’s patient database. Data analyzed included patient demographics, T category at presentation (using AJCC 8th edition criteria), and magnetic resonance imaging (MRI) features, including T1 post-contrast enhancement patterns and T2 signal characteristics. The MRIs were reviewed by a CAQ-certified neuroradiologist. The location of the LGACC—including the distance of the posterior tumor margin from the superior orbital fissure (SOF), bone remodeling and destruction, involvement of the extra-ocular muscles (EOMs), temporal fossa, pterygopalatine fossa, sinonasal cavity, intracranial compartment, and the presence of perineural tumor spread—were analyzed. Results: The study included a total of 39 patients. A total of 16 patients with a median age of 52.6 years were in Group 1, and 23 patients with a median age of 46.1 years were in Group 2. A greater T-category and larger size of the tumor were significantly more common in Group 1. Smooth tumor margins were significantly more common in Group 2, while irregular margins were significantly more common in Group 1. The distance from the posterior tumor margin to the SOF was significantly less in Group 1. Crossing the vertical midline of the orbit, bone destruction, and the invasion of the EOMs were significantly more common in Group 1. Extension to involve the cavernous sinus, pterygopalatine foramen, and sinonasal cavity, as well as perineural spread, were only present in Group 1. No significant difference was noted between T1 post-contrast patterns and T2 characteristics. Conclusions: MRI features of LGACC more commonly associated with orbital exenteration as opposed to eye-sparing surgery included larger size and irregular margins, as well as the posterior tumor margin being closer to the SOF, crossing the vertical midline of the orbit, bone destruction, and the involvement of the EOMS, cavernous sinus, pterygopalatine foramen, and sinonasal cavity. These MRI features may aid oculoplastic surgeons in determining which patients may be candidates for successful eye-sparing surgery for the treatment of LGACC.